{
    "2020-09-29": [
        [
            {
                "time": "",
                "original_text": "A股头条之上市公司（9.30）",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：子公司已具备重组新冠疫苗生产条件和资格",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新冠疫苗",
                        "生产条件",
                        "资格"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：全资子公司已具备重组新型冠状病毒疫苗(CHO细胞)的生产条件和资格",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "全资子公司",
                        "重组新型冠状病毒疫苗",
                        "CHO细胞",
                        "生产条件",
                        "资格"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：具备重组新型冠状病毒疫苗的生产条件和资格",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新型冠状病毒疫苗",
                        "生产条件",
                        "资格"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)：子公司变更药品生产许可证生产范围增加重组新型冠状病毒疫苗(CHO细胞)",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "子公司",
                        "药品生产许可证",
                        "重组新型冠状病毒疫苗",
                        "CHO细胞"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "发生了什么？军工股突然大爆发，两只20%涨停",
                "features": {
                    "keywords": [
                        "军工股",
                        "大爆发",
                        "涨停"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "军工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗股走软，智飞生物、长春高新、康泰生物、复星医药、华兰生物、万泰生物普跌",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "智飞生物",
                        "长春高新",
                        "康泰生物",
                        "复星医药",
                        "华兰生物",
                        "万泰生物",
                        "普跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}